Lung cancer risk assessment could be improved over existing guidelines by a four-protein biomarker blood test.
Browsing: Taxonomy > Biomarkers
Discover an effective biomarker for improving the management of colorectal cancer patients by enhancing the efficiency of detection and efficacy of targeting treatment.
Discover the issues concerning tissue-biomarker development and the hurdles faced in reaching the goal of truly personalized medicine.
In this research article discover the potential role of quantitative MRI (qMRI) utilizing T1/T2 ratios to differentiate benign from malignant breast lesions.
In this patient perspective article, you can find out about the challenges associated with diagnosing mesothelioma and the promising role that biomarkers are playing.
A new assay test for five cancer-associated genes with the goal of aiding prediction of neuroblastoma in children has been reported.
In this review article the authors highlight how nanotechnology could help enhance cancer diagnosis.
Available to view on demand
Learn about a study that was accomplished as a means to explore the hypothesis that circulating concentrations of decoy receptors and/or ligands, as well as disease-specific ligand degradation all regulate RTK signaling in vivo.
Prospective clinical trial results demonstrate that a biomarker blood test could detect lung cancer recurrence on average 6 months earlier than CT scans.